{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T22:45:45Z","timestamp":1786574745246,"version":"build-2736575974"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T00:00:00Z","timestamp":1549411200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006315","name":"Reumafonds","doi-asserted-by":"publisher","award":["12-02-303"],"award-info":[{"award-number":["12-02-303"]}],"id":[{"id":"10.13039\/501100006315","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["Consolidator grant no. 310372"],"award-info":[{"award-number":["Consolidator grant no. 310372"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["Spinoza grant 2016"],"award-info":[{"award-number":["Spinoza grant 2016"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006209","name":"Radboud Universitair Medisch Centrum","doi-asserted-by":"publisher","award":["MSc-PhD grant"],"award-info":[{"award-number":["MSc-PhD grant"]}],"id":[{"id":"10.13039\/501100006209","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Romanian Ministry of European Funds","award":["P_37_762, MySMIS 103587"],"award-info":[{"award-number":["P_37_762, MySMIS 103587"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13075-019-1834-x","type":"journal-article","created":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T13:04:10Z","timestamp":1549458250000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Romidepsin suppresses monosodium urate crystal-induced cytokine production through upregulation of suppressor of cytokine signaling 1 expression"],"prefix":"10.1186","volume":"21","author":[{"given":"M. C. P.","family":"Cleophas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. O.","family":"Cri\u015fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Kl\u00fcck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Hoogerbrugge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. T.","family":"Netea-Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. A.","family":"Dinarello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. G.","family":"Netea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. A. B.","family":"Joosten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,6]]},"reference":[{"key":"1834_CR1","doi-asserted-by":"crossref","unstructured":"Elfishawi MM, Zleik N, Kvrgic Z, Michet CJ Jr, Crowson CS, Matteson EL, et al. The rising incidence of gout and the increasing burden of comorbidities: a population-based study over 20 years. J Rheumatol. 2018;45(4):574\u20139.","DOI":"10.3899\/jrheum.170806"},{"key":"1834_CR2","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S0140-6736(09)60883-7","volume":"375","author":"P Richette","year":"2010","unstructured":"Richette P, Bardin T. Gout. Lancet. 2010;375:318\u201328.","journal-title":"Gout. Lancet"},{"key":"1834_CR3","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1136\/ard.2007.076232","volume":"67","author":"L Annemans","year":"2008","unstructured":"Annemans L, Spaepen E, Gaskin M, Bonnemaire M, Malier V, Gilbert T, et al. Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005. Ann Rheum Dis. 2008;67:960\u20136.","journal-title":"Ann Rheum Dis"},{"key":"1834_CR4","doi-asserted-by":"crossref","unstructured":"Kiadaliri AA, Uhlig T, Englund M. Burden of gout in the Nordic region, 1990-2015: findings from the Global Burden of Disease Study 2015. Scand J Rheumatol. 2018;47(5):410\u20137.","DOI":"10.1080\/03009742.2017.1405461"},{"key":"1834_CR5","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1136\/annrheumdis-2013-204463","volume":"74","author":"CF Kuo","year":"2015","unstructured":"Kuo CF, Grainge MJ, Mallen C, Zhang W, Doherty M. Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study. Ann Rheum Dis. 2015;74:661\u20137.","journal-title":"Ann Rheum Dis"},{"key":"1834_CR6","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.1002\/art.30520","volume":"63","author":"Y Zhu","year":"2011","unstructured":"Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum. 2011;63:3136\u201341.","journal-title":"Arthritis Rheum"},{"key":"1834_CR7","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1007\/s11926-013-0400-9","volume":"16","author":"MA Martillo","year":"2014","unstructured":"Martillo MA, Nazzal L, Crittenden DB. The crystallization of monosodium urate. Curr Rheumatol Rep. 2014;16:400.","journal-title":"Curr Rheumatol Rep"},{"key":"1834_CR8","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.3899\/jrheum.080938","volume":"36","author":"N Schlesinger","year":"2009","unstructured":"Schlesinger N, Norquist JM, Watson DJ. Serum urate during acute gout. J Rheumatol. 2009;36:1287\u20139.","journal-title":"J Rheumatol"},{"key":"1834_CR9","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature04516","volume":"440","author":"F Martinon","year":"2006","unstructured":"Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature. 2006;440:237\u201341.","journal-title":"Nature"},{"key":"1834_CR10","doi-asserted-by":"publisher","first-page":"3237","DOI":"10.1002\/art.27667","volume":"62","author":"LA Joosten","year":"2010","unstructured":"Joosten LA, Netea MG, Mylona E, Koenders MI, Malireddi RK, Oosting M, et al. Engagement of fatty acids with Toll-like receptor 2 drives interleukin-1beta production via the ASC\/caspase 1 pathway in monosodium urate monohydrate crystal-induced gouty arthritis. Arthritis Rheum. 2010;62:3237\u201348.","journal-title":"Arthritis Rheum"},{"key":"1834_CR11","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1136\/annrheumdis-2014-206258","volume":"75","author":"MC Cleophas","year":"2016","unstructured":"Cleophas MC, Crisan TO, Lemmers H, Toenhake-Dijkstra H, Fossati G, Jansen TL, et al. Suppression of monosodium urate crystal-induced cytokine production by butyrate is mediated by the inhibition of class I histone deacetylases. Ann Rheum Dis. 2016;75:593\u2013600.","journal-title":"Ann Rheum Dis"},{"key":"1834_CR12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","volume":"76","author":"P Richette","year":"2017","unstructured":"Richette P, Doherty M, Pascual E, Barskova V, Becce F, Castaneda-Sanabria J, et al. 2016 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis. 2017;76:29\u201342.","journal-title":"Ann Rheum Dis"},{"key":"1834_CR13","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.amjmed.2010.09.012","volume":"124","author":"RT Keenan","year":"2011","unstructured":"Keenan RT, O'Brien WR, Lee KH, Crittenden DB, Fisher MC, Goldfarb DS, et al. Prevalence of contraindications and prescription of pharmacologic therapies for gout. Am J Med. 2011;124:155\u201363.","journal-title":"Am J Med"},{"key":"1834_CR14","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s40801-016-0093-2","volume":"3","author":"T Gu","year":"2016","unstructured":"Gu T, Shah N, Deshpande G, Tang DH, Eisenberg DF. Comparing biologic cost per treated patient across indications among adult US managed care patients: a retrospective cohort study. Drugs Real World Outcomes. 2016;3:369\u201381.","journal-title":"Drugs Real World Outcomes"},{"key":"1834_CR15","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1126\/science.1175371","volume":"325","author":"C Choudhary","year":"2009","unstructured":"Choudhary C, Kumar C, Gnad F, Nielsen ML, Rehman M, Walther TC, et al. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science. 2009;325:834\u201340.","journal-title":"Science"},{"key":"1834_CR16","doi-asserted-by":"publisher","first-page":"a018713","DOI":"10.1101\/cshperspect.a018713","volume":"6","author":"E Seto","year":"2014","unstructured":"Seto E, Yoshida M. Erasers of histone acetylation: the histone deacetylase enzymes. Cold Spring Harb Perspect Biol. 2014;6:a018713.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"1834_CR17","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/nrm2346","volume":"9","author":"XJ Yang","year":"2008","unstructured":"Yang XJ, Seto E. The Rpd3\/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men. Nat Rev Mol Cell Biol. 2008;9:206\u201318.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1834_CR18","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1172\/JCI69738","volume":"124","author":"AC West","year":"2014","unstructured":"West AC, Johnstone RW. New and emerging HDAC inhibitors for cancer treatment. J Clin Invest. 2014;124:30\u20139.","journal-title":"J Clin Invest"},{"key":"1834_CR19","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1002\/cncr.22585","volume":"109","author":"L Pan","year":"2007","unstructured":"Pan L, Lu J, Wang X, Han L, Zhang Y, Han S, et al. Histone deacetylase inhibitor trichostatin a potentiates doxorubicin-induced apoptosis by up-regulating PTEN expression. Cancer. 2007;109:1676\u201388.","journal-title":"Cancer"},{"key":"1834_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0095520","volume":"9","author":"H Zhang","year":"2014","unstructured":"Zhang H, Zhao B, Huang C, Meng XM, Bian EB, Li J. Melittin restores PTEN expression by down-regulating HDAC2 in human hepatocelluar carcinoma HepG2 cells. PLoS One. 2014;9:e95520.","journal-title":"PLoS One"},{"key":"1834_CR21","doi-asserted-by":"publisher","first-page":"e150","DOI":"10.1016\/j.oraloncology.2009.05.563","volume":"45","author":"YH Gan","year":"2009","unstructured":"Gan YH, Zhang S. PTEN\/AKT pathway involved in histone deacetylases inhibitor induced cell growth inhibition and apoptosis of oral squamous cell carcinoma cells. Oral Oncol. 2009;45:e150\u20134.","journal-title":"Oral Oncol"},{"key":"1834_CR22","first-page":"265","volume":"2015","author":"S Dhar","year":"1853","unstructured":"Dhar S, Kumar A, Li K, Tzivion G, Levenson AS. Resveratrol regulates PTEN\/Akt pathway through inhibition of MTA1\/HDAC unit of the NuRD complex in prostate cancer. Biochim Biophys Acta. 1853;2015:265\u201375.","journal-title":"Biochim Biophys Acta"},{"key":"1834_CR23","doi-asserted-by":"publisher","first-page":"1250684","DOI":"10.1126\/science.1250684","volume":"345","author":"SC Cheng","year":"2014","unstructured":"Cheng SC, Quintin J, Cramer RA, Shepardson KM, Saeed S, Kumar V, et al. mTOR- and HIF-1alpha-mediated aerobic glycolysis as metabolic basis for trained immunity. Science. 2014;345:1250684.","journal-title":"Science"},{"key":"1834_CR24","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.cell.2017.07.029","volume":"170","author":"DA Fruman","year":"2017","unstructured":"Fruman DA, Chiu H, Hopkins BD, Bagrodia S, Cantley LC, Abraham RT. The PI3K pathway in human disease. Cell. 2017;170:605\u201335.","journal-title":"Cell"},{"key":"1834_CR25","doi-asserted-by":"publisher","first-page":"5485","DOI":"10.1073\/pnas.1620910114","volume":"114","author":"TO Crisan","year":"2017","unstructured":"Crisan TO, Cleophas MCP, Novakovic B, Erler K, van de Veerdonk FL, Stunnenberg HG, et al. Uric acid priming in human monocytes is driven by the AKT-PRAS40 autophagy pathway. Proc Natl Acad Sci U S A. 2017;114:5485\u201390.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1834_CR26","doi-asserted-by":"publisher","first-page":"37372","DOI":"10.1074\/jbc.M608372200","volume":"281","author":"RJ Deberardinis","year":"2006","unstructured":"Deberardinis RJ, Lum JJ, Thompson CB. Phosphatidylinositol 3-kinase-dependent modulation of carnitine palmitoyltransferase 1A expression regulates lipid metabolism during hematopoietic cell growth. J Biol Chem. 2006;281:37372\u201380.","journal-title":"J Biol Chem"},{"key":"1834_CR27","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1101\/gad.1492806","volume":"20","author":"I Shiojima","year":"2006","unstructured":"Shiojima I, Walsh K. Regulation of cardiac growth and coronary angiogenesis by the Akt\/PKB signaling pathway. Genes Dev. 2006;20:3347\u201365.","journal-title":"Genes Dev"},{"key":"1834_CR28","doi-asserted-by":"publisher","first-page":"3316","DOI":"10.1128\/MCB.22.10.3316-3326.2002","volume":"22","author":"D Ungureanu","year":"2002","unstructured":"Ungureanu D, Saharinen P, Junttila I, Hilton DJ, Silvennoinen O. Regulation of Jak2 through the ubiquitin-proteasome pathway involves phosphorylation of Jak2 on Y1007 and interaction with SOCS-1. Mol Cell Biol. 2002;22:3316\u201326.","journal-title":"Mol Cell Biol"},{"key":"1834_CR29","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/S1097-2765(03)00490-8","volume":"12","author":"A Ryo","year":"2003","unstructured":"Ryo A, Suizu F, Yoshida Y, Perrem K, Liou YC, Wulf G, et al. Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65\/RelA. Mol Cell. 2003;12:1413\u201326.","journal-title":"Mol Cell"},{"key":"1834_CR30","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/ni1299","volume":"7","author":"A Mansell","year":"2006","unstructured":"Mansell A, Smith R, Doyle SL, Gray P, Fenner JE, Crack PJ, et al. Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating mal degradation. Nat Immunol. 2006;7:148\u201355.","journal-title":"Nat Immunol"},{"key":"1834_CR31","doi-asserted-by":"publisher","first-page":"333","DOI":"10.2119\/molmed.2011.00116","volume":"17","author":"CA Dinarello","year":"2011","unstructured":"Dinarello CA, Fossati G, Mascagni P. Histone deacetylase inhibitors for treating a spectrum of diseases not related to cancer. Mol Med. 2011;17:333\u201352.","journal-title":"Mol Med"},{"key":"1834_CR32","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/sj.bjp.0707165","volume":"150","author":"HS Lin","year":"2007","unstructured":"Lin HS, Hu CY, Chan HY, Liew YY, Huang HP, Lepescheux L, et al. Anti-rheumatic activities of histone deacetylase (HDAC) inhibitors in vivo in collagen-induced arthritis in rodents. Br J Pharmacol. 2007;150:862\u201372.","journal-title":"Br J Pharmacol"},{"key":"1834_CR33","doi-asserted-by":"publisher","first-page":"391","DOI":"10.2119\/molmed.2011.00058","volume":"17","author":"LA Joosten","year":"2011","unstructured":"Joosten LA, Leoni F, Meghji S, Mascagni P. Inhibition of HDAC activity by ITF2357 ameliorates joint inflammation and prevents cartilage and bone destruction in experimental arthritis. Mol Med. 2011;17:391\u20136.","journal-title":"Mol Med"},{"key":"1834_CR34","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.joca.2007.10.014","volume":"16","author":"Y Nasu","year":"2008","unstructured":"Nasu Y, Nishida K, Miyazawa S, Komiyama T, Kadota Y, Abe N, et al. Trichostatin a, a histone deacetylase inhibitor, suppresses synovial inflammation and subsequent cartilage destruction in a collagen antibody-induced arthritis mouse model. Osteoarthr Cartil. 2008;16:723\u201332.","journal-title":"Osteoarthr Cartil"},{"key":"1834_CR35","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1002\/art.30238","volume":"63","author":"J Vojinovic","year":"2011","unstructured":"Vojinovic J, Damjanov N, D'Urzo C, Furlan A, Susic G, Pasic S, et al. Safety and efficacy of an oral histone deacetylase inhibitor in systemic-onset juvenile idiopathic arthritis. Arthritis Rheum. 2011;63:1452\u20138.","journal-title":"Arthritis Rheum"},{"key":"1834_CR36","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s10787-012-0166-0","volume":"21","author":"MD Cantley","year":"2013","unstructured":"Cantley MD, Haynes DR. Epigenetic regulation of inflammation: progressing from broad acting histone deacetylase (HDAC) inhibitors to targeting specific HDACs. Inflammopharmacology. 2013;21:301\u20137.","journal-title":"Inflammopharmacology"},{"key":"1834_CR37","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.it.2011.04.001","volume":"32","author":"MR Shakespear","year":"2011","unstructured":"Shakespear MR, Halili MA, Irvine KM, Fairlie DP, Sweet MJ. Histone deacetylases as regulators of inflammation and immunity. Trends Immunol. 2011;32:335\u201343.","journal-title":"Trends Immunol"},{"issue":"11","key":"1834_CR38","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1093\/emboj\/21.11.2672","volume":"21","author":"G Lagger","year":"2002","unstructured":"Lagger G, O\u2019Carroll D, Rembold M, Khier H, Tischler J, Weitzer G, et al. Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression. EMBO J. 2002;21(11):2672\u201381.","journal-title":"EMBO J"},{"issue":"14","key":"1834_CR39","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1101\/gad.1563807","volume":"21","author":"RL Montgomery","year":"2007","unstructured":"Montgomery RL, Davis CA, Potthoff MJ, Haberland M, Fielitz J, Qi X, et al. Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility. Genes Dev. 2007;21(14):1790\u2013802.","journal-title":"Genes Dev"},{"issue":"Pt 3","key":"1834_CR40","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1042\/bj20021321","volume":"370","author":"AJM Ruijter de","year":"2003","unstructured":"de Ruijter AJM, van Gennip AH, Caron HN, Kemp S, van Kuilenburg ABP. Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J. 2003;370(Pt 3):737\u201349.","journal-title":"Biochem J"},{"key":"1834_CR41","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/417455a","volume":"417","author":"C Hubbert","year":"2002","unstructured":"Hubbert C, Guardiola A, Shao R, Kawaguchi Y, Ito A, Nixon A, et al. HDAC6 is a microtubule-associated deacetylase. Nature. 2002;417:455\u20138.","journal-title":"Nature"},{"key":"1834_CR42","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/ni.2550","volume":"14","author":"T Misawa","year":"2013","unstructured":"Misawa T, Takahama M, Kozaki T, Lee H, Zou J, Saitoh T, et al. Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome. Nat Immunol. 2013;14:454\u201360.","journal-title":"Nat Immunol"},{"key":"1834_CR43","doi-asserted-by":"crossref","unstructured":"Ashburner BP, Westerheide SD, Baldwin AS. The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol Cell Biol. 2001;21(20):7065\u201377.","DOI":"10.1128\/MCB.21.20.7065-7077.2001"},{"key":"1834_CR44","doi-asserted-by":"crossref","unstructured":"Chen L-F, Fischle W, Verdin E, Greene WC. Duration of Nuclear NF-kappa B Action Regulated by Reversible Acetylation. Science. 2001;293(5535):1653\u20137.","DOI":"10.1126\/science.1062374"},{"key":"1834_CR45","doi-asserted-by":"crossref","unstructured":"Chen L-F, Williams SA, Mu Y, Nakano H, Duerr JM, Buckbinder L, et al. NF-\u03baB RelA phosphorylation regulates RelA acetylation. Mol Cell Biol. 2005;25(18):7966\u201375.","DOI":"10.1128\/MCB.25.18.7966-7975.2005"},{"key":"1834_CR46","doi-asserted-by":"crossref","unstructured":"Choi YS, Jeong S. PI3-kinase and PDK-1 regulate HDAC1-mediated transcriptional repression of transcription factor NF-kappaB. Mol Cells. 2005;20(2):241\u20136.","DOI":"10.1016\/S1016-8478(23)13223-7"},{"key":"1834_CR47","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1101\/gad.1662308","volume":"22","author":"HC Dan","year":"2008","unstructured":"Dan HC, Cooper MJ, Cogswell PC, Duncan JA, Ting JP, Baldwin AS. Akt-dependent regulation of NF-{kappa}B is controlled by mTOR and raptor in association with IKK. Genes Dev. 2008;22:1490\u2013500.","journal-title":"Genes Dev"},{"key":"1834_CR48","unstructured":"Administration UFaD. ISTODAX (romidepsin) Label. 2009. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2009\/022393lbl.pdf . [updated 06-11-2009. Accessed 30 May 2018]."},{"issue":"8","key":"1834_CR49","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1101\/gr.168781.113","volume":"24","author":"H Rafehi","year":"2014","unstructured":"Rafehi H, Balcerczyk A, Lunke S, Kaspi A, Ziemann M, Kn H, et al. Vascular histone deacetylation by pharmacological HDAC inhibition. Genome Res. 2014;24(8):1271\u201384.","journal-title":"Genome Res"},{"issue":"3","key":"1834_CR50","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/cr.2011.22","volume":"21","author":"AJ Bannister","year":"2011","unstructured":"Bannister AJ, Kouzarides T. Regulation of chromatin by histone modifications. Cell Res. 2011;21(3):381\u201395.","journal-title":"Cell Res"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-019-1834-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-019-1834-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-019-1834-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T15:46:04Z","timestamp":1720971964000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-019-1834-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,6]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1834"],"URL":"https:\/\/doi.org\/10.1186\/s13075-019-1834-x","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,6]]},"assertion":[{"value":"5 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Buffy coats from healthy donors were obtained after written informed consent from Sanquin Blood Bank, Nijmegen, the Netherlands. Blood collection from Cowden syndrome patients was approved by the accredited medical research and ethics committee of the region Arnhem\/Nijmegen in the Netherlands (reference 2014\/147). Written informed consent was obtained before inclusion. All experiments with human material were performed according to the declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"50"}}